We are live on ! Find out more
APC

Alpine Peaks Capital Portfolio holdings

AUM $85.4M
1-Year Est. Return 11.24%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.4M
AUM Growth
-$13.8M
Cap. Flow
-$23.2M
Cap. Flow %
-27.19%
Top 10 Hldgs %
64.97%
Holding
22
New
1
Increased
1
Reduced
18
Closed
2
Avg Time Held Equity + Options
14.4 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
13 quarters
Avg Time Held Equity only
14.4 quarters
Top 10 Avg Time Held Equity only
5.6 quarters
Top 20 Avg Time Held Equity only
13 quarters

Top Buys

Rank Stock Value
1
CELH icon
Celsius Holdings
CELH
+$830K
2
JKHY icon
Jack Henry & Associates
JKHY
+$317K

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$3.27M
2
LFUS icon
Littelfuse
LFUS
+$2.69M
3
QLYS icon
Qualys
QLYS
+$2.44M
4
CGNX icon
Cognex
CGNX
+$1.96M
5
TNET icon
TriNet
TNET
+$1.66M

Sector Composition

Rank Sector Weight
1 Technology 33.82%
2 Industrials 25.8%
3 Healthcare 25.61%
4 Consumer Discretionary 10.5%
5 Consumer Staples 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HEI.A icon
1
HEICO Corp Class A
HEI.A
$31.1B
$7.32M 8.57%
28,368
-5,301
-16% -$1.21M
2021 Q4
18 quarters
WST icon
2
West Pharmaceutical
WST
$25.9B
$6.89M 8.07%
19,191
-10,692
-36% -$3.27M
2021 Q4
18 quarters
CGNX icon
3
Cognex
CGNX
$10.7B
$6.49M 7.6%
89,599
-32,320
-27% -$1.96M
2021 Q4
18 quarters
BFAM icon
4
Bright Horizons
BFAM
$3.36B
$5.5M 6.44%
77,539
-15,312
-16% -$1.11M
2021 Q4
18 quarters
USPH icon
5
US Physical Therapy
USPH
$1.27B
$5.25M 6.15%
76,487
-18,537
-20% -$1.26M
2021 Q4
18 quarters
MEDP icon
6
Medpace
MEDP
$17.2B
$4.99M 5.84%
9,418
-1,938
-17% -$894K
2021 Q4
18 quarters
LFUS icon
7
Littelfuse
LFUS
$10.9B
$4.96M 5.81%
10,897
-6,203
-36% -$2.69M
2024 Q2
8 quarters
JKHY icon
8
Jack Henry & Associates
JKHY
$10.5B
$4.75M 5.56%
34,480
+2,233
+7% +$317K
2023 Q1
13 quarters
TECH icon
9
Bio-Techne
TECH
$11.4B
$4.73M 5.54%
66,960
-7,040
-10% -$380K
2025 Q1
5 quarters
TREX icon
10
Trex
TREX
$4.53B
$4.59M 5.38%
91,762
-30,577
-25% -$1.27M
2022 Q4
14 quarters
EVTC icon
11
Evertec
EVTC
$1.77B
$4.53M 5.31%
163,126
-25,078
-13% -$667K
2021 Q4
18 quarters
WMS icon
12
Advanced Drainage Systems
WMS
$9.45B
$3.98M 4.66%
25,344
-5,326
-17% -$761K
2024 Q1
9 quarters
ROL icon
13
Rollins
ROL
$15.5B
$3.47M 4.06%
83,108
-6,860
-8% -$351K
2022 Q1
17 quarters
DSGX icon
14
Descartes Systems
DSGX
$7.12B
$3.45M 4.04%
49,757
-14,143
-22% -$1.01M
2025 Q1
5 quarters
TRMB icon
15
Trimble
TRMB
$14B
$3.3M 3.86%
64,451
-11,532
-15% -$682K
2021 Q4
18 quarters
WAB icon
16
Wabtec
WAB
$48.4B
$3.14M 3.68%
11,655
-5,825
-33% -$1.54M
2021 Q4
18 quarters
BBSI icon
17
Barrett Business Services
BBSI
$768M
$3M 3.51%
84,352
-4,000
-5% -$126K
2021 Q4
18 quarters
IPAR icon
18
Interparfums
IPAR
$3.58B
$2.88M 3.37%
25,722
-11,480
-31% -$1.08M
2021 Q4
18 quarters
QLYS icon
19
Qualys
QLYS
$6.93B
$1.39M 1.63%
10,142
-24,763
-71% -$2.44M
2021 Q4
18 quarters
CELH icon
20
Celsius Holdings
CELH
$7.24B
$771K 0.9%
+26,332
New +$830K
2026 Q2
0 quarters
MRVI icon
21
CALL
Maravai LifeSciences
MRVI
$1.11B
– –
-100,000
Closed -$283K –
TNET icon
22
TriNet
TNET
$3.01B
– –
-45,650
Closed -$1.66M –

Similar funds

Alpine Peaks Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Alpine Peaks Capital held 22 positions worth $85.4M, down 14% from $99.2M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Alpine Peaks Capital withdrew a net $23.2M in Q2 2026, closing 2 positions and reducing 18 holdings. Its most notable exit was TriNet, an estimated $1.66M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alpine Peaks Capital opened a new position in Celsius Holdings worth $771K.

  • Alpine Peaks Capital's largest Q2 2026 buy was Celsius Holdings: 26,332 shares worth $771K.
  • Alpine Peaks Capital added most to Jack Henry & Associates in Q2 2026, an estimated $317K increase.
  • Alpine Peaks Capital's biggest Q2 2026 reduction was West Pharmaceutical, cutting an estimated $3.27M.
  • Alpine Peaks Capital fully exited TriNet in Q2 2026, selling an estimated $1.66M.
  • Alpine Peaks Capital's ten largest holdings make up 65% of its $85.4M portfolio in Q2 2026.
  • Alpine Peaks Capital opened 1 new position and closed 2 in Q2 2026.
  • Alpine Peaks Capital's portfolio value fell 14% quarter-over-quarter to $85.4M.

Based on Alpine Peaks Capital's 13F filing for Q2 2026, filed 14 Aug 2026.